Literature DB >> 8113663

The experience in using whole pelvic irradiation in management of massive bleeding from carcinoma of the uterine cervix.

P Kraiphibul1, S Srisupundit, S Kiatgumjaikajorn, V Pairachvet.   

Abstract

At the Radiation Therapy Section, Ramathibodi Hospital, from June 1, 1981 to May 31, 1991, there were 35 out of 1,683 new cases of carcinoma of the uterine cervix which presented with massive bleeding per vagina. All were treated via cobalt-60 teletherapy covering the whole pelvic region by 12 x 12 cm2 or 16 x 16 cm2 field sizes. Eighteen cases received a radiation dose of 300 cGy/fraction while 16 cases received 400 cGy and one case received 600 cGy. All had bleeding controlled within 2-6 fractions, twenty-two cases (62.9%) within 3 fractions and 34 cases (97.1%) within 5 fractions. There was no severe acute complication in all patients. In 10 patients who were followed up to the range of 3-70 months, median 16.5 showed no severe late complications.

Entities:  

Mesh:

Year:  1993        PMID: 8113663

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  3 in total

1.  Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.

Authors:  George U Eleje; Ahizechukwu C Eke; Gabriel O Igberase; Anthony O Igwegbe; Lydia I Eleje
Journal:  Cochrane Database Syst Rev       Date:  2019-03-19

2.  An International Consensus on the Design of Prospective Clinical-Translational Trials in Spatially Fractionated Radiation Therapy for Advanced Gynecologic Cancer.

Authors:  Beatriz E Amendola; Anand Mahadevan; Jesus Manuel Blanco Suarez; Robert J Griffin; Xiaodong Wu; Naipy C Perez; Daniel S Hippe; Charles B Simone; Majid Mohiuddin; Mohammed Mohiuddin; James W Snider; Hualin Zhang; Quynh-Thu Le; Nina A Mayr
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

3.  Bleeding in Locally Invasive Pelvic Malignancies: Is Hypofractionated Radiation Therapy a Safe and Effective Non-Invasive Option for Securing Hemostasis? A Single Institution Perspective.

Authors:  Muhammad Shuja; Saadiya Nazli; Muhammad Atif Mansha; Asif Iqbal; Reham Mohamed; Mutahir A Tunio; Eyad F Alsaeed; Mushabbab Asiri; Yasser Bayoumi
Journal:  Cureus       Date:  2018-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.